Table 1.
Demographic Information of All Subjects Used in This Study.
| Groups | Training datasets | Validation datasets | P-Value |
|---|---|---|---|
| Control Group | Patients recruited in training phase | Patients recruited in validation phase | |
| 140 urocystitis patients | 60 urocystitis patients | ||
| Age (years) | Age (years) | 0.58 | |
| <66: 74 (52.85%) | <66: 29 (48.33%) | ||
| ≥66: 66 (47.15%) | ≥66: 31 (51.67%) | ||
| Cigarette smokers | Cigarette smokers | 0.32 | |
| 37 (26.43%) | 17 (28.3%) | ||
| Alcohol drinkers | Alcohol drinkers | 0.24 | |
| 19 (13.57%) | 8 (13.33%) | ||
| Sex | Sex | 0.34 | |
| Male: 92 (65.71%) | Male: 39 (65.00%) | ||
| Female: 48 (34.29%) | Female: 21 (35.00%) | ||
| Condition | Condition | 0.89 | |
| Cystitis: 140 (100%) | Cystitis: 60 (100%) | ||
| Bladder Cancer Group | Patients recruited in training phase | Patients recruited in validation phase | |
| 140 NMIBC patients | 60 NMIBC patients | ||
| Age (years) | Age (years) | 0.52 | |
| <66: 72 (51.43%) | <66: 33 (55.00%) | ||
| ≥66: 68 (48.57%) | ≥66: 27 (45.00%) | ||
| Cigarette smokers | Cigarette smokers | 0.31 | |
| 45 (32.14%) | 19 (31.7%) | ||
| Alcohol drinkers | Alcohol drinkers | 0.27 | |
| 23 (16.43%) | 9 (15.00%) | ||
| Sex | Sex | 0.93 | |
| Male: 96 (68.57%) | Male: 41 (68.33%) | ||
| Female: 44 (31.43%) | Female: 19 (31.67%) | ||
| Tumor stage | Tumor stage | 0.21 | |
| Ta-T1: 78 (55.71%) | Ta-T1: 35 (58.33%) | ||
| T2-T4: 62 (44.29%) | T2-T4: 25 (41.67%) |